XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Stock Plans | 12 Months Ended
--- | ---
Jan. 01, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock Plans |
1 2. | Stock Plans
Incentive Compensation Plans and Winfrey Amendment Option On May 6, 2008, the Company’s shareholders approved the 2008 Stock Incentive Plan (the “2008 Plan”). On May 6, 2014, the Company’s shareholders approved the 2014 Stock Incentive Plan (as amended and restated, the “2014 Plan”, and together with the 2008 Plan, the “Stock Plans”), which replaced the 2008 Plan for all equity-based awards granted on or after May 6, 2014. The 2014 Plan is designed to promote the long-term financial interests and growth of the Company by attracting, motivating and retaining employees with the ability to contribute to the success of the business and to align compensation for the Company’s employees over a multi-year period directly with the interests of the shareholders of the Company. The Company’s long-term equity incentive compensation program has historically included time-vesting non-qualified stock option and/or restricted stock unit (“RSUs”) (including performance-based stock unit with both time- and performance-vesting criteria (“PSUs”)) awards. From time to time, the Company has granted fully-vested shares of its common stock to individuals in connection with special circumstances. The Company’s Board of Directors or a committee thereof administers the 2014 Plan. Under the 2014 Plan, grants may take the following forms at the Company’s Board of Directors’ Compensation and Benefits Committee’s (the “Compensation Committee”) discretion: non-qualified stock options, incentive stock options, stock appreciation rights, RSUs, restricted stock and other stock-based awards. As of January 1, 2022, the maximum number of shares of common stock available for grant under the 2014 Plan was 12,500, subject to increase and adjustment as set forth in the 2014 Plan. Under the 2014 Plan, the Company also grants fully-vested shares of its common stock to certain members of its Board of Directors. While these shares are fully vested, the directors are restricted from selling these shares while they are still serving on the Company’s Board of Directors subject to limited exceptions. During the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, the Company granted to members of the Company’s Board of Directors an aggregate of 29, 31 and 29 fully-vested shares, respectively, and recognized compensation expense of $757, $688 and $756, respectively. Under the Winfrey Amendment Option (as defined below), in fiscal 2020 the Company granted Ms. Winfrey a fully vested option to purchase 3,276 shares of the Company’s common stock as more fully described in Note 22. The Company issues common stock for share-based compensation awards from treasury stock. The total compensation cost that has been charged against income for share-based compensation awards and the Winfrey Amendment Option, as applicable, was $21,348, $55,013 and $20,471 for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. Such amounts have been included as a component of selling, general and administrative expenses. The total income tax benefit recognized in the Company’s consolidated statements of net income for all share-based compensation awards was $5,175, $10,915 and $2,141 for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. The tax benefits realized from options exercised and RSUs and PSUs vested totaled $7,999, $8,426 and $2,840 for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. No compensation costs were capitalized. As of January 1, 2022, there was $31,877 of total unrecognized compensation cost related to the stock options, RSUs and PSUs granted under the Stock Plans. That cost is expected to be recognized over a weighted-average period of approximately 1.5 years. Stock Option Awards with Time-Vesting Criteria Stock options with time-vesting criteria (“Time-Vesting Options”) are exercisable based on the terms and conditions outlined in the applicable award agreement. Time-Vesting Options outstanding at January 1, 2022, January 2, 2021 and December 28, 2019 vest over a period of two to four years and the expiration term is seven to ten years. Time-Vesting Options outstanding at January 1, 2022, January 2, 2021 and December 28, 2019 have an exercise price between $3.97 and $60.00 per share. The Company did not grant Time-Vesting Options in fiscal 2019. The fair value of each of these option awards is estimated on the date of grant using the Black-Scholes option pricing model with the weighted average assumptions noted in the following table. Expected volatility is based on the historical volatility of the Company’s common stock. Since the Company’s option exercise history is limited, it has estimated the expected term of these options (other than the options with a seven-year term) to be the midpoint between the vesting period and the contractual term of each option. For options with a seven-year contractual term, the expected term is equal to 7 years. The risk-free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant which most closely corresponds to the expected term of the Time-Vesting Options. The dividend yield is based on the Company’s historic average dividend yield.
|  | January 1, |  |  | January 2, |
|  | 2022 |  |  | 2021 |
Dividend yield |  | 0.0% |  |  | 0.0% |
Volatility |  | 56.7% |  |  | 56.5% - 56.7% |
Risk-free interest rate |  | 1.13% |  |  | 0.45% - 0.52% |
Expected term (years) |  |  | 6.5 |  |  | 5.9 - 6.5 |
Option Activity A summary of all option activity under the Stock Plans and the Initial Option Agreement (as defined below) for the fiscal year ended January 1, 2022 is presented below.
|  |  |  |  |  |  |  |  |  | Weighted- |  |  |  |  |
|  |  |  |  |  | Weighted- |  |  | Average |  |  |  |  |
|  |  |  |  |  | Average |  |  | Remaining |  |  | Aggregate |
|  |  |  |  |  | Exercise |  |  | Contractual |  |  | Intrinsic |
|  | Shares |  |  | Price |  |  | Life (Yrs.) |  |  | Value |
Outstanding at January 2, 2021 |  |  | 6,360 |  |  | $ | 33.09 |  |  |  |  |  |  |  |  |
Granted |  |  | 354 |  |  | $ | 29.43 |  |  |  |  |  |  |  |  |
Exercised |  |  | (606 | ) |  | $ | 7.02 |  |  |  |  |  |  |  |  |
Cancelled |  |  | (402 | ) |  | $ | 25.97 |  |  |  |  |  |  |  |  |
Outstanding at January 1, 2022 |  |  | 5,706 |  |  | $ | 36.13 |  |  |  | 4.0 |  |  | $ | 5,028 |
Exercisable at January 1, 2022 |  |  | 5,172 |  |  | $ | 37.38 |  |  |  | 3.5 |  |  | $ | 5,028 |
The weighted-average grant-date fair value of all options granted (including the Winfrey Amendment Option) was $15.64, $9.98 and $0.00 for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. The total intrinsic value of all options exercised (including options granted under the Initial Option Agreement) was $18,497, $24,841 and $1,105 for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. Cash received from Time-Vesting Options exercised during the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019 was $4,469, $8,176 and $1,076, respectively. Restricted Stock Unit Awards with Time-Vesting Criteria RSUs are exercisable based on the terms outlined in the applicable award agreement. The RSUs generally vest over a period of two to four years. The fair value of RSUs is determined using the closing market price of the Company’s common stock on the date of grant. A summary of RSU activity under the Stock Plans for the fiscal year ended January 1, 2022 is presented below.
|  |  |  |  |  | Weighted-Average |
|  |  |  |  |  | Grant-Date Fair |
|  | Shares |  |  | Value |
Outstanding at January 2, 2021 |  |  | 1,699 |  |  | $ | 21.32 |
Granted |  |  | 1,204 |  |  | $ | 24.29 |
Vested |  |  | (736 | ) |  | $ | 24.60 |
Forfeited |  |  | (572 | ) |  | $ | 21.51 |
Outstanding at January 1, 2022 |  |  | 1,595 |  |  | $ | 21.99 |
The weighted-average grant-date fair value of RSUs granted was $24.29, $19.40 and $19.09 for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. The total fair value of RSUs vested during the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019 was $18,097, $15,015 and $12,268, respectively. Performance-Based Stock Unit Awards with Time- and Performance-Vesting Criteria In fiscal 2019, the Company granted 280.1 PSUs having both time- and performance-vesting criteria. The time-vesting criteria for these PSUs will be satisfied upon continued employment (with limited exceptions) on the third anniversary of the grant date. The performance-vesting criteria for these PSUs will be satisfied if the Company has achieved a certain annual operating income objective for the performance period of fiscal 2021. Pursuant to these awards, the number of PSUs that become vested, if any, upon the satisfaction of both vesting criteria, shall be equal to (x) the target number of PSUs granted multiplied by (y) the applicable achievement percentage, rounded down to avoid the issuance of fractional shares. The Company is currently accruing compensation expense to what it believes is the probable outcome upon vesting. In fiscal 2018, the Company granted 81.3 PSUs having both time- and performance-vesting criteria. The time-vesting criteria for these PSUs was satisfied upon continued employment (with limited exceptions) on May 15, 2021. The performance-vesting criteria for these PSUs was not satisfied and 0 PSUs became vested in fiscal 2021 upon the satisfaction of the time-vesting criteria. The Company accrued compensation expense in an amount equal to the outcome upon vesting. In fiscal 2017, the Company granted 98.5 PSUs in May 2017 and 47.9 PSUs in July 2017, all having both time- and performance-vesting criteria (the “2017 PSUs”). The time-vesting criteria for these PSUs was satisfied upon continued employment (with limited exceptions) on May 15, 2020. The performance-vesting criteria for two-thirds of these PSUs was satisfied when the Company achieved, in the case of the May 2017 awards, certain annual operating income objectives and, in the case of the July 2017 award, certain net income or operating income objectives, as applicable for each of the fiscal 2017 and fiscal 2018 performance years. The performance-vesting criteria for the fiscal 2019 performance year was not satisfied. When the performance measure was met, if at all, for a particular 2017 Award Performance Year (i.e., each fiscal year over a three-year period, fiscal 2017 through fiscal 2019), that portion of units was “banked” for potential issuance following the satisfaction of the time-vesting criteria. Such portion of units “banked” was equal to (x) the target number of PSUs granted for the applicable 2017 Award Performance Year multiplied by (y) the applicable achievement percentage (166.67% in the case of fiscal 2017 and fiscal 2018), rounded down to avoid the issuance of fractional shares. Pursuant to these awards, the number of PSUs that became vested in fiscal 2020 upon the satisfaction of the time-vesting criteria was 122.6. The Company accrued compensation expense in an amount equal to the outcome upon vesting. In fiscal 2016, the Company granted 289.9 PSUs having both time- and performance-vesting criteria. The time-vesting criteria for these PSUs was satisfied upon continued employment (with limited exceptions) on the third anniversary of the grant date. The performance-vesting criteria for these PSUs was satisfied when the Company achieved a Debt Ratio (as defined in the applicable term sheet for these PSU awards and based on a Debt to EBITDAS ratio (each, as defined therein)) at levels at or below 4.5x over the performance period from December 31, 2017 to December 29, 2018. Pursuant to these awards, the number of PSUs that became vested in fiscal 2019 upon the satisfaction of the time-vesting criteria of 219.3 was calculated as (x) the target number of PSUs granted multiplied by (y) 166.67%, the applicable Debt Ratio achievement percentage, rounded down to avoid the issuance of fractional shares. The Company accrued compensation expense in an amount equal to the outcome upon vesting. The fair value of PSUs is determined using the closing market price of the Company’s common stock on the date of grant. A summary of PSU activity under the 2014 Plan for the fiscal year ended January 1, 2022 is presented below.
|  |  |  |  |  | Weighted-Average |
|  |  |  |  |  | Grant-Date Fair |
|  | Shares |  |  | Value |
Outstanding at January 2, 2021 |  |  | 295 |  |  | $ | 31.46 |
Granted |  |  | — |  |  | $ | — |
Vested |  |  | — |  |  | $ | — |
Forfeited |  |  | (94 | ) |  | $ | 58.21 |
Outstanding at January 1, 2022 |  |  | 201 |  |  | $ | 18.94 |
The weighted-average grant-date fair value of PSUs granted and/or incremental shares vested was $0.00, $28.09 and $17.51 during the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. The total fair value of PSUs vested during the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019 was $0, $3,443 and $2,891, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration